Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study - Saltz, L B; Clarke, S; Díaz-Rubio, E (J Clin Oncol, 2008)
, et al.